Cardiac Surgery News and Research

RSS

SORIN uses KIKA's advanced EDC platform to evaluate effectiveness of Heart Valves

KIKA™ Clinical Solutions announced that SORIN Group is using KIKA's advanced EDC platform for clinical trial asset management on two open observational, multi-center, Real Life Registries to evaluate the effectiveness of SORIN Heart Valves.

8 Dec 2010

Scott & White Healthcare’s Cardiac Rehabilitation Program receives AACVPR accreditation

The Cardiac Rehabilitation Program at Scott & White Healthcare in Temple has received accreditation from the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR).

24 Nov 2010

13-hour lifesaving heart/liver transplant performed on pulmonary atresia patient

A 28-year old man from Georgia, David Krech, is recovering from a rare, lifesaving heart/liver transplant on October 15 at the University of Maryland Medical Center. The 13-hour operation followed a five-month journey as he awaited a suitable heart and liver donor.

17 Nov 2010

Cardiac surgery leads to stroke, seizure and neurological complications: Report

Strokes, seizures and other neurological complications related to heart surgery account for "considerable morbidity and mortality," Loyola University Health System neurologists report in the November issue of the journal Hospital Practice.

17 Nov 2010

Neurologic complications remain an important cause of morbidity and mortality after heart surgeries

16 Nov 2010

Bluhm Cardiovascular Institute implants VAD device to help individuals with advanced heart failure

The Bluhm Cardiovascular Institute of Northwestern Memorial Hospital recently implanted a patient with two of the smallest experimental ventricular assist devices (VADs) currently available for study in humans. VADs are designed to assist either the right (RVAD) or left (LVAD) ventricle, or both (BiVAD) at once.

15 Nov 2010

New techniques to stop ventricular arrhythmias in high-risk patients

New techniques now being used at UCLA allow doctors to more precisely target certain areas of the heart to stop ventricular arrhythmias — serious abnormal rhythms in the heart's lower chambers — in high-risk patients.

9 Nov 2010

JenaValve commences CE-Mark study for transapical TAVI system

JenaValve™ Technology, Inc., a medical device company specialized in developing transcatheter valve replacement products, announced today the start of its multicenter CE-mark study. The first two implantations of its transapical TAVI system were performed by Dr. med. Hendrik Treede at the Universitäres Herzzentrum Hamburg.

3 Nov 2010

CareChex releases new study on University Hospital Care in the U.S.

CareChex, a division of The Delta Group specializing in rating the quality of hospital and physician care, today released a new study, An Assessment of the Quality of University Hospital Care in the U.S., that investigates whether or not university hospitals outperform other hospitals on objective measures of quality.

2 Nov 2010

CorMatrix's ECM technology reduces postoperative atrial fibrillation in CABG patients

CorMatrix Cardiovascular, Inc., a medical device company dedicated to developing and delivering unique extracellular matrix (ECM) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, announced today that a retrospective study demonstrated that reconstructing the pericardium using ECM Technology in patients undergoing primary isolated coronary artery bypass grafting (CABG) contributed to a statistically significant and clinically meaningful reduction in the rate of new onset postoperative atrial fibrillation.

26 Oct 2010

PolyMedix plans PMX-60056 Phase 2 clinical trial in interventional cardiology

PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has announced plans for a Phase 2 clinical trial of PMX-60056 in interventional cardiology, and the establishment of a focused Heptagonist Clinical Advisory Board (CAB). PMX-60056 is a synthetic small-molecule designed to reverse the anticoagulant activity of heparin and low molecular weight heparins (LMWH).

21 Oct 2010

Study finds massive blood transfusion associated with severe complications

A study presented at this year's American Society of Anesthesiologists Annual Meeting indicates that massive blood transfusion is associated with a significant increase in perioperative risk for mortality, cardiopulmonary complications, and wound-related and infectious complications in the long term.

20 Oct 2010

Aspirin before cardiac surgery reduces postoperative cardiocerebral complications

A study presented at the American Society of Anesthesiologists 2010 Annual Meeting revealed that use of aspirin before cardiac surgery reduced postoperative cardiocerebral complications, including stroke, myocardial ischemia, heart block and cardiac arrest by more than 33 percent when compared to patients who did not use aspirin.

20 Oct 2010

Study finds link between blood sugar levels and mortality risk in diabetic patients after non-cardiac surgeries

A clinical study presented at ANESTHESIOLOGY 2010 discovered that diabetics who presented for non-cardiac surgery with near normal blood sugar levels were at increased risk of death, as compared with their non-diabetic counterparts.

19 Oct 2010

Study finds wide variability in use of blood transfusions for coronary artery bypass graft surgery

A study that includes data on more than 100,000 patients who underwent coronary artery bypass graft surgery finds that there is wide variability among hospitals in the U.S. on the use of blood transfusions, without a large difference in the rate of death, suggesting that many transfusions may be unnecessary, according to a study in the October 13 issue of JAMA. Another study in this issue of JAMA examines the effect of a restrictive transfusion strategy on outcomes after cardiac surgery.

13 Oct 2010

Study examines restrictive strategy of RBC transfusion in patients undergoing elective cardiac surgery

Use of stricter guidelines for the use of red blood cell transfusions for patients undergoing cardiac surgery was associated similar rates of death and severe illness compared to patients who received more transfusions, according to a study in the October 13 issue of JAMA. Another study in this issue of JAMA examines the variation in the use of blood transfusions for patients undergoing cardiac surgery.

13 Oct 2010

Japanese MHLW approves CryoLife's BioGlue Surgical Adhesive for aortic dissections

CryoLife, Inc. an implantable biological medical device and cardiovascular tissue processing company, today announced that its BioGlue Surgical Adhesive has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for use in the repair of aortic dissections.

8 Oct 2010

Estech adds COBRA Revolution Bipolar Clamp to ablation product line

Estech, a leading provider of minimally invasive cardiac surgery devices, today announced the launch of its COBRA Revolution™ Bipolar Clamp for use in surgical ablation procedures. The new instrument enables deep transmural lesion formation after a single application and is the only clamp to feature reversible jaws, which uniquely allows surgeons to follow anatomic contours, for unprecedented ease of use and efficiency.

5 Oct 2010

North Shore-LIJ Health System granted approval to extend cardiac surgery program to Southside Hospital

The New York State Hospital Review and Planning Council today approved North Shore-LIJ Health System's request to extend its open-heart surgery program to Southside Hospital in Bay Shore, bringing one of New York's most renowned cardiothoracic surgery programs to Suffolk County's south shore. The council's action will be forwarded to State Health Commissioner Richard Daines, MD, for final approval.

1 Oct 2010

Gersak develops Convergent Procedure for atrial fibrillation

During the recent Atrial Fibrillation Session of the Techno College at the European Association of Cardiac Thoracic Surgeons in Geneva, Switzerland, Professor Borut Gersak, Head of Cardiac Surgery from University Medical Center in Ljubljana, Slovenia challenged his audience of more than 1,000 medical professionals to think differently about existing atrial fibrillation surgical approaches.

23 Sep 2010